z-logo
open-access-imgOpen Access
Anti-Rheumatic Drugs May Ameliorate the Clinical Course and Outcome of COVID-19 In Rheumatoid Arthritis Patients
Author(s) -
Eleftherios Pelechas,
Vassiliki Drossou,
Paraskevi V. Voulgari,
Alexandros A. Drosos
Publication year - 2022
Publication title -
mediterranean journal of rheumatology
Language(s) - English
Resource type - Journals
ISSN - 2529-198X
DOI - 10.31138/mjr.33.1.68
Subject(s) - rheumatoid arthritis , medicine , immunology , tumor necrosis factor alpha , immune dysregulation , immune system , disease , chemokine , covid-19 , arthritis , rheumatology , autoimmune disease , rheumatoid factor , infectious disease (medical specialty)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom